Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Oxaliplatin × 30 days × Clear all

Sponsor

Conditions

Stomach Neoplasms 16 Colorectal Neoplasms 16 Rectal Neoplasms 10 Esophageal Neoplasms 10 Colonic Neoplasms 10 Lymphoma, Large B-Cell, Diffuse 9 Adenocarcinoma Of Esophagus 8 Carcinoma, Non-Small-Cell Lung 6 Ovarian Neoplasms 5 Neoplasm Metastasis 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Pancreatic Neoplasms 3 Neoplasms 3 Lung Neoplasms 3 Endometrial Neoplasms 3 Cholangiocarcinoma 3 Adenocarcinoma 3 Pathologic Complete Response 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Follicular 2 Lymphoma 2 Gastrointestinal Neoplasms 2 Gallbladder Neoplasms 2 Colorectal Adenocarcinoma 2 Carcinoma, Pancreatic Ductal 2 Biliary Tract Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1

Interventions

pembrolizumab 2 fludarabine 2 blinatumomab 2 tislelizumab 1 tisagenlecleucel 1 tetrathiomolybdate 1 relugolix 1 nilotinib 1 isatuximab 1 inavolisib 1 giredestrant 1 fludarabine phosphate 1 enzalutamide 1 abemaciclib 1 Transplantation 1 Monatide (IMS 3015) 1 Melphalan 1 Lenalidomide 1 Immunotherapy 1 Imatinib Mesylate 1 HMPL-013 1 Docetaxel 1 Dexamethasone 1 Dasatinib 1 Cyclophosphamide 1 Capecitabine 1 Calcium Dobesilate 1 Biological Assay 1 ALT-803 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡